Skip to main content
. 2022 Jul 6;41:e2021145. doi: 10.1590/1984-0462/2023/41/2021145

Table 3. Prevalence/confidence interval of metabolic syndrome components in Brazilian adolescents.

Study Prevalence (%) or 95%CI* of MS components Nutritional status (%)
AO High BP HG Low HDL-C HTG
Quintão et al. 17 1.4 (males)
4.0 (females)
16.7 (males)
3.0 (females)
0 (males)
1.0 (females)
30.6 (males)
35.0 (females)
0 (males)
4.0 (females)
OW: 11.6
OB: 2.9
Alvarez et al. 18 9.0
(6.30–12.90)
12.5
(7.90–17.05)
22.3
(13.30–31.70)
32.5
(23.60–41.40)
3.7
(1.90–5.40)
OW–OB: 15.8
Stabelini Neto et al. 19 Not informed 18.9 4.7 29.2 18.3 LW: 5.2 ET: 77.8
OW: 11.0 OB: 6.0
de Sousa et al. 20 46.8 18.4 16.0 54.0 27.6 Not informed
Furtado Neto e Ribeiro 21 12.2 12.2 0.40 37.4 17.7 LW: 30.3 ET: 33.1
OW: 11.1 OB: 25.4
Granjeiro et al. 22 2.0
(0.64–4.70)
12.9
(8.76–18.03)
4.5
(2.19–8.07)
23.3
(17.83–29.47);
6.9
(3.99–11.09)
OW–OB: 14.4
Kuschnir et al. 23 12.6
(11.60–13.70)
8.2
(7.60–8.90)
4.1
(3.50–4.80)
32.7
(30.30–35.20)
4.6
(4.10–5.10)
Not informed
Assis et al. 24 19.9
(15.52–24.82)
7.6
(4.89–11.21)
2.9
(1.37–5.58)
23.5
(18.84–28.70)
8.0
(5.16–11.59)
OB: 27.5
Pani et al. 25 11.3 1.9 7.5 22.6 20.7 OW: 17.0 OB: 7.5
dos Santos et al. 26 15.3 8.8 5.1 25.2 6.6 LW: 6.6 ET: 67.5
OW:15.3 OB: 10.6
Reuter et al. 28 7.6 18.7 14.1 3.3 4.7 LW–ET: 72.2
OW: 16.6 OB: 11.2
Guilherme et al. 29 Not informed 15.4 12.4 Not informed Not informed Not informed
Lustosa et al. 30 11.9 5.2 18.6 50.5 4.3 LW: 2.5 ET: 80.7
OW: 12.5 OB: 4.3
*

Some studies showed the prevalence of components MS, whereas others showed the prevalence and confidence interval for those components. MS: metabolic syndrome; 95%CI: confidence interval; AO: abdominal obesity; BP: blood pressure; HG: hyperglycemia; HDL-C: high-density lipoprotein cholesterol; HTG: high serum triglyceride; OW: overweight; OB: obesity; LW: low weight; ET: eutrophy.